Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Dec 13, 2024

Veerhealth Care Completes FDA Assessment; Expects Repeat Export Orders From USA Clients

Veerhealth Care Completes FDA Assessment; Expects Repeat Export Orders From USA Clients
Ayurvedic healthcare firm Veerhealth Care on Friday announced the successful closure of the US Food and Drug Administration assessment of Form 4003, a significant milestone in its global expansion plans.Source: Veerhealth Care website

Ayurvedic healthcare firm Veerhealth Care on Friday announced the successful closure of the US Food and Drug Administration assessment of Form 4003, a significant milestone in its global expansion plans. The FDA's confirmation that no further action is required signifies the company's adherence to rigorous quality and regulatory standards, a company statement said.

According to the statement, this achievement opens doors for Veerhealth Care to penetrate the lucrative US market and cater to the growing demand for natural and Ayurvedic healthcare products.

Bhavin Shah, Managing Director of Veerhealth Care Ltd, said, "Successful completion of assessment by the USFDA against document submitted for the RRA, would enhance the company's current standing and its reputation and visibility in the market."

The company is expected to get monthly repeat export orders from clients of the USA for its products in the Oral Care category, he added.

"It's a testament to the quality of our products and services. We remain committed to delivering excellence and expanding our global footprint in the healthcare and personal care sector," Shah said.

Veerhealth Care has already made significant strides in its international expansion. The company has secured export orders worth Rs 3.50 crore, demonstrating its strong global presence.

Furthermore, a strategic partnership with a leading US institutional supplier holds the potential for substantial revenue growth, with monthly and annual order values estimated at Rs 1.50 crore and Rs 18 crore, respectively.

To further solidify its global footprint, Veerhealth Care has recently hosted a visit from a prominent Russian corporate group.

The company is expecting to reach Revenue of Rs 100 crore with net profit of 10% in the next 2 to 3 years.

VeerHealth Care is involved in the business of manufacturing and supplying Ayurvedic medicines, oral care products and personal care products.

All finished formulations are manufactured at its manufacturing facility in Vapi, Gujarat, designed to comply with international requirements with validated systems.

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search